Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 284

1.

Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model.

Otero M, Calarota SA, Felber B, Laddy D, Pavlakis G, Boyer JD, Weiner DB.

Vaccine. 2004 Apr 16;22(13-14):1782-90.

PMID:
15068862
2.
3.
4.

HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.

Jiang W, Ren L, Jin N.

J Virol Methods. 2007 Dec;146(1-2):266-73. Epub 2007 Sep 14.

PMID:
17868910
5.

Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.

Shinoda K, Xin KQ, Jounai N, Kojima Y, Tamura Y, Okada E, Kawamoto S, Okuda K, Klinman D, Okuda K.

Vaccine. 2004 Sep 9;22(27-28):3676-90.

PMID:
15315847
6.

Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.

Li W, Li S, Hu Y, Tang B, Cui L, He W.

Vaccine. 2008 Jun 19;26(26):3282-90. doi: 10.1016/j.vaccine.2008.03.081. Epub 2008 Apr 18.

PMID:
18472194
7.
8.

Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines.

Xu R, Megati S, Roopchand V, Luckay A, Masood A, Garcia-Hand D, Rosati M, Weiner DB, Felber BK, Pavlakis GN, Sidhu MK, Eldridge JH, Egan MA.

Vaccine. 2008 Sep 2;26(37):4819-29. doi: 10.1016/j.vaccine.2008.06.103. Epub 2008 Jul 25.

PMID:
18657584
9.

Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses.

Tritel M, Stoddard AM, Flynn BJ, Darrah PA, Wu CY, Wille U, Shah JA, Huang Y, Xu L, Betts MR, Nabel GJ, Seder RA.

J Immunol. 2003 Sep 1;171(5):2538-47.

10.

Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.

Abaitua F, Rodríguez JR, Garzón A, Rodríguez D, Esteban M.

Virus Res. 2006 Mar;116(1-2):11-20. Epub 2005 Oct 7.

PMID:
16214252
11.
12.

Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.

Chong SY, Egan MA, Kutzler MA, Megati S, Masood A, Roopchard V, Garcia-Hand D, Montefiori DC, Quiroz J, Rosati M, Schadeck EB, Boyer JD, Pavlakis GN, Weiner DB, Sidhu M, Eldridge JH, Israel ZR.

Vaccine. 2007 Jun 21;25(26):4967-82. Epub 2007 Feb 14.

PMID:
17335943
13.

IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine.

Xin KQ, Hamajima K, Sasaki S, Tsuji T, Watabe S, Okada E, Okuda K.

Vaccine. 1999 Feb 26;17(7-8):858-66.

PMID:
10067692
14.

Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity.

Sang H, Pisarev VM, Munger C, Robinson S, Chavez J, Hatcher L, Parajuli P, Guo Y, Talmadge JE.

Vaccine. 2003 Jun 20;21(21-22):3019-29.

PMID:
12798646
15.

Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost.

Billaut-Mulot O, Idziorek T, Loyens M, Capron A, Bahr GM.

Vaccine. 2001 Apr 6;19(20-22):2803-11.

PMID:
11282190
16.

HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates.

Wille-Reece U, Flynn BJ, Loré K, Koup RA, Kedl RM, Mattapallil JJ, Weiss WR, Roederer M, Seder RA.

Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15190-4. Epub 2005 Oct 11.

17.

HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompatibility class II compartment, and elicits enhanced immune responses.

Marques ET Jr, Chikhlikar P, de Arruda LB, Leao IC, Lu Y, Wong J, Chen JS, Byrne B, August JT.

J Biol Chem. 2003 Sep 26;278(39):37926-36. Epub 2003 Jun 24.

18.

Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus gag DNA vaccines.

Caulfield MJ, Wang S, Smith JG, Tobery TW, Liu X, Davies ME, Casimiro DR, Fu TM, Simon A, Evans RK, Emini EA, Shiver J.

J Virol. 2002 Oct;76(19):10038-43.

19.

[Study on the immunogenicity of HIV-1 gag vaccine].

Jiang WZ, Jin NY, Li ZJ, Zhang LS.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2004 May;20(3):272-3. Chinese.

PMID:
15193215
20.

Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.

Megede JZ, Otten GR, Doe B, Liu H, Srivastava R, Greer C, Legg H, Tang T, Polo JM, Donnelly JJ, Ulmer JB, Barnett SW.

Vaccine. 2006 Apr 5;24(15):2755-63. Epub 2006 Jan 19.

PMID:
16460840

Supplemental Content

Support Center